UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The hydrogen sulphide‐releasing derivative of diclofenac protects against ischaemia–reperfusion injury in the isolated rabbit heart

British journal of pharmacology, 2008-01, Vol.153 (1), p.100-109

2008

Volltextzugriff (PDF)

Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity

Oncogene, 2009-10, Vol.28 (43), p.3837-3846

2009

Volltextzugriff (PDF)

Modulation of angiogenesis by dithiolethione‐modified NSAIDs and valproic acid

British journal of pharmacology, 2007-05, Vol.151 (1), p.142-151

2007

Volltextzugriff (PDF)

Hydrogen sulphide‐releasing diclofenac derivatives inhibit breast cancer‐induced osteoclastogenesis in vitro and prevent osteolysis ex vivo

British journal of pharmacology, 2012-03, Vol.165 (6), p.1914-1925

2012

Volltextzugriff (PDF)

A comparison of the anti‐inflammatory and anti‐nociceptive activity of nitroaspirin and aspirin

British journal of pharmacology, 2000-01, Vol.129 (2), p.343-350

2000

Volltextzugriff (PDF)

Effects of non‐steroidal anti‐inflammatory drugs on cyclo‐oxygenase and lipoxygenase activity in whole blood from aspirin‐sensitive asthmatics vs healthy donors

British journal of pharmacology, 2002-12, Vol.137 (7), p.1031-1038

2002

Volltextzugriff (PDF)

H2S RELEASING ASPIRIN PROTECTS AMYLOID BETA INDUCED CELL TOXICITY IN BV-2 MICROGLIAL CELLS

Neuroscience, 2011-10, Vol.193, p.80-88

2011

Volltextzugriff (PDF)

Interaction of a Selective Cyclooxygenase-2 Inhibitor with Aspirin and NO-Releasing Aspirin in the Human Gastric Mucosa

Proceedings of the National Academy of Sciences - PNAS, 2003-09, Vol.100 (19), p.10937-10941

2003

Volltextzugriff (PDF)

Nitric-oxide releasing molecules: a new class of drugs with several major indications

Current pharmaceutical design, 2002-01, Vol.8 (3), p.201-213

2002

Volltextzugriff (PDF)

Corrigendum to “H2S releasing aspirin protects amyloid beta induced cell toxicity in BV-2 microglial cells” [Neuroscience 193 (2011) 80–88]

Neuroscience, 2012-09, Vol.221, p.225-225

2012

Volltextzugriff (PDF)

Gastrointestinal safety of nitric oxide–derived aspirin is related to inhibition of ICE-like cysteine proteases in rats

Gastroenterology (New York, N.Y. 1943), 1999-05, Vol.116 (5), p.1089-1106

1999

Volltextzugriff (PDF)

NO-aspirin: mechanism of action and gastrointestinal safety

Digestive and liver disease, 2003-05, Vol.35, p.S9-S19

2003

Volltextzugriff (PDF)

Addition of nitric oxide via nitroflurbiprofen enhances the material properties of early healing of young rat Achilles tendons

Inflammation research, 2003-06, Vol.52 (6), p.230-237

2003

Volltextzugriff (PDF)

IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs

The Journal of immunology (1950), 2000-11, Vol.165 (9), p.5245-5254

2000

Volltextzugriff (PDF)

Identification of hydrogen sulfide releasing compounds as novel antiresorptive and antitumour agents

Bone (New York, N.Y.), 2011-01, Vol.48 (1), p.S44-S44

2011

Volltextzugriff (PDF)

Nitric oxide-releasing aspirin derivative, NCX 4016, promotes reparative angiogenesis and prevents apoptosis and oxidative stress in a mouse model of peripheral ischemia

Arteriosclerosis, thrombosis, and vascular biology, 2004-11, Vol.24 (11), p.2082-2087

2004

Volltextzugriff (PDF)

Enhanced anti-inflammatory effects of a nitric oxide–releasing derivative of mesalamine in rats

Gastroenterology (New York, N.Y. 1943), 1999-09, Vol.117 (3), p.557-566

1999

Volltextzugriff (PDF)

Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative

The Journal of clinical investigation, 1995-12, Vol.96 (6), p.2711-2718

1995

Volltextzugriff (PDF)

NO‐naproxen vs. naproxen: ulcerogenic, analgesic and anti‐inflammatory effects

Alimentary pharmacology & therapeutics, 1997-02, Vol.11 (1), p.69-79

1997

Volltextzugriff (PDF)

Nitroaspirin Corrects Immune Dysfunction in Tumor-Bearing Hosts and Promotes Tumor Eradication by Cancer Vaccination

Proceedings of the National Academy of Sciences - PNAS, 2005-03, Vol.102 (11), p.4185-4190

2005

Volltextzugriff (PDF)

Nitro-aspirin (NCX4016) reduces brain damage induced by focal cerebral ischemia in the rat

Neuroscience letters, 2001-04, Vol.302 (2), p.121-124

2001

Volltextzugriff (PDF)

Nitric oxide‐releasing NSAIDs inhibit interleukin‐1β converting enzyme‐like cysteine proteases and protect endothelial cells from apoptosis induced by TNFα

Alimentary pharmacology & therapeutics, 1999-03, Vol.13 (3), p.421-435

1999

Volltextzugriff (PDF)

Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: A proof of concept endoscopic study

Gastroenterology (New York, N.Y. 1943), 2003-03, Vol.124 (3), p.600-607

2003

Volltextzugriff (PDF)

The effects of sham and full spinalization on the antinociceptive effects of NCX-701 (nitroparacetamol) in monoarthritic rats

Neuropharmacology, 2003-09, Vol.45 (3), p.412-419

2003

Volltextzugriff (PDF)

Role of the Arginine-Nitric Oxide Pathway in the Regulation of Vascular Smooth Muscle Cell Proliferation

Proceedings of the National Academy of Sciences - PNAS, 2001-03, Vol.98 (7), p.4202-4208

2001

Volltextzugriff (PDF)

1 – 25 von 187

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(150)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(129)
Life Sciences & Biomedicine
(120)
Animals
(118)
Rats
(82)
Male
(75)
Biological And Medical Sciences
(73)
Medical Sciences
(71)
Pharmacology & Pharmacy
(69)
Pharmacology. Drug Treatments
(56)
Humans
(51)
Female
(43)
Anti-Inflammatory Agents, Non-Steroidal - Pharmacology
(41)
Aspirin - Pharmacology
(41)
Aspirin - Analogs & Derivatives
(39)
Nitric Oxide
(37)
Dose-Response Relationship, Drug
(34)
Nitric Oxide - Metabolism
(29)
Mice
(27)
Rats, Wistar
(24)
Gastroenterology & Hepatology
(22)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The hydrogen sulphide‐releasing derivative of diclofenac protects against ischaemia–reperfusion injury in the isolated rabbit heart

Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity

Modulation of angiogenesis by dithiolethione‐modified NSAIDs and valproic acid

Hydrogen sulphide‐releasing diclofenac derivatives inhibit breast cancer‐induced osteoclastogenesis in vitro and prevent osteolysis ex vivo

A comparison of the anti‐inflammatory and anti‐nociceptive activity of nitroaspirin and aspirin

Effects of non‐steroidal anti‐inflammatory drugs on cyclo‐oxygenase and lipoxygenase activity in whole blood from aspirin‐sensitive asthmatics vs healthy donors

H2S RELEASING ASPIRIN PROTECTS AMYLOID BETA INDUCED CELL TOXICITY IN BV-2 MICROGLIAL CELLS

Interaction of a Selective Cyclooxygenase-2 Inhibitor with Aspirin and NO-Releasing Aspirin in the Human Gastric Mucosa

Nitric-oxide releasing molecules: a new class of drugs with several major indications

Corrigendum to “H2S releasing aspirin protects amyloid beta induced cell toxicity in BV-2 microglial cells” [Neuroscience 193 (2011) 80–88]

Gastrointestinal safety of nitric oxide–derived aspirin is related to inhibition of ICE-like cysteine proteases in rats

NO-aspirin: mechanism of action and gastrointestinal safety

Addition of nitric oxide via nitroflurbiprofen enhances the material properties of early healing of young rat Achilles tendons

IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs

Identification of hydrogen sulfide releasing compounds as novel antiresorptive and antitumour agents

Nitric oxide-releasing aspirin derivative, NCX 4016, promotes reparative angiogenesis and prevents apoptosis and oxidative stress in a mouse model of peripheral ischemia

Enhanced anti-inflammatory effects of a nitric oxide–releasing derivative of mesalamine in rats

Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative

NO‐naproxen vs. naproxen: ulcerogenic, analgesic and anti‐inflammatory effects

Nitroaspirin Corrects Immune Dysfunction in Tumor-Bearing Hosts and Promotes Tumor Eradication by Cancer Vaccination

Nitro-aspirin (NCX4016) reduces brain damage induced by focal cerebral ischemia in the rat

Nitric oxide‐releasing NSAIDs inhibit interleukin‐1β converting enzyme‐like cysteine proteases and protect endothelial cells from apoptosis induced by TNFα

Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: A proof of concept endoscopic study

The effects of sham and full spinalization on the antinociceptive effects of NCX-701 (nitroparacetamol) in monoarthritic rats

Role of the Arginine-Nitric Oxide Pathway in the Regulation of Vascular Smooth Muscle Cell Proliferation

Suchergebnisse filtern